INDSWFTLABPharmaceuticals
Ind Swift Laboratories Ltd — Balance Sheet
₹131.43
+0.97%
Ind Swift Laboratories Ltd Balance Sheet (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Construction In Progress | 0.00 | 8.66 Cr | 10.36 Cr | 10.70 Cr |
| Other Properties | 51000.00 | 47.69 Cr | 47.13 Cr | 45.93 Cr |
| Machinery Furniture Equipment | 8.13 Cr | 957.76 Cr | 947.08 Cr | 931.32 Cr |
| Buildings And Improvements | 0.00 | 269.67 Cr | 268.69 Cr | 267.47 Cr |
| Land And Improvements | 0.00 | 55.79 Cr | 56.02 Cr | 56.05 Cr |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Assets | 661.13 Cr | 1.16K Cr | 1.08K Cr | 944.18 Cr |
| Other Current Assets | 1000.00 | 1000.00 | 1000.00 | 68.09 Cr |
| Assets Held For Sale Current | 0.00 | 1.40 Cr | 2.01 Cr | 2.30 Cr |
| Prepaid Assets | 40.25 Cr | 73.74 Cr | 64.28 Cr | 63.56 Cr |
| Inventory | 10.46 Cr | 438.60 Cr | 428.50 Cr | 375.67 Cr |
| Finished Goods | 10.24 Cr | 128.19 Cr | 117.13 Cr | 106.64 Cr |
| Ordinary Shares Number | 5.91 Cr | 5.91 Cr | 5.91 Cr | 5.91 Cr |
| Share Issued | 5.91 Cr | 5.91 Cr | 5.91 Cr | 5.91 Cr |
| Total Debt | 16.62 Cr | 862.10 Cr | 953.02 Cr | 1.01K Cr |
| Tangible Book Value | 931.46 Cr | 681.93 Cr | 599.97 Cr | 594.09 Cr |
| Invested Capital | 948.08 Cr | 1.54K Cr | 1.55K Cr | 1.61K Cr |
| Working Capital | 439.85 Cr | 793.43 Cr | 740.87 Cr | 629.66 Cr |
| Net Tangible Assets | 931.46 Cr | 681.93 Cr | 599.97 Cr | 594.09 Cr |
| Capital Lease Obligations | 0.00 | 0.56 Cr | 0.53 Cr | 0.51 Cr |
| Common Stock Equity | 931.46 Cr | 681.93 Cr | 600.97 Cr | 603.51 Cr |
| Total Capitalization | 942.62 Cr | 1.43K Cr | 1.45K Cr | 1.49K Cr |
| Total Equity Gross Minority Interest | 931.44 Cr | 681.93 Cr | 600.86 Cr | 603.42 Cr |
| Minority Interest | -0.02 Cr | 0.00 | -0.11 Cr | -0.09 Cr |
| Stockholders Equity | 931.46 Cr | 681.93 Cr | 600.97 Cr | 603.51 Cr |
| Other Equity Interest | 872.37 Cr | -19000.00 | 541.17 Cr | 543.70 Cr |
| Fixed Assets Revaluation Reserve | 0.00 | 183.41 Cr | 196.49 Cr | 210.75 Cr |
| Retained Earnings | 391.65 Cr | -29.33 Cr | -78.05 Cr | -76.24 Cr |
| Additional Paid In Capital | 307.31 Cr | 307.31 Cr | 307.31 Cr | 307.31 Cr |
| Capital Stock | 59.09 Cr | 59.81 Cr | 59.81 Cr | 59.81 Cr |
| Common Stock | 59.09 Cr | 59.81 Cr | 59.81 Cr | 59.81 Cr |
| Total Liabilities Net Minority Interest | 233.67 Cr | 1.14K Cr | 1.20K Cr | 1.22K Cr |
| Total Non Current Liabilities Net Minority Interest | 12.39 Cr | 771.04 Cr | 865.47 Cr | 900.51 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | 1.23 Cr | 17.79 Cr | 17.03 Cr | 15.73 Cr |
| Non Current Deferred Revenue | 0.00 | 0.12 Cr | 0.15 Cr | 0.17 Cr |
| Long Term Debt And Capital Lease Obligation | 11.16 Cr | 753.13 Cr | 848.29 Cr | 884.61 Cr |
| Long Term Capital Lease Obligation | 0.00 | 0.53 Cr | 0.51 Cr | 0.48 Cr |
| Long Term Debt | 11.16 Cr | 752.60 Cr | 847.78 Cr | 884.13 Cr |
| Long Term Provisions | 1.23 Cr | 17.79 Cr | 17.03 Cr | 15.73 Cr |
| Current Liabilities | 221.28 Cr | 371.09 Cr | 334.47 Cr | 314.52 Cr |
| Other Current Liabilities | 8.41 Cr | 10.24 Cr | 8.90 Cr | 12.72 Cr |
| Current Debt And Capital Lease Obligation | 5.46 Cr | 108.97 Cr | 104.73 Cr | 120.75 Cr |
| Current Capital Lease Obligation | 0.00 | 0.03 Cr | 0.03 Cr | 0.03 Cr |
| Current Debt | 5.46 Cr | 108.94 Cr | 104.70 Cr | 120.72 Cr |
| Current Provisions | 101.79 Cr | 12.25 Cr | 5.39 Cr | 0.98 Cr |
| Payables | 202.05 Cr | 231.57 Cr | 188.82 Cr | 153.92 Cr |
| Other Payable | 6.29 Cr | 15.32 Cr | 12.87 Cr | 15.10 Cr |
| Total Tax Payable | 101.79 Cr | 12.25 Cr | — | — |
| Accounts Payable | 93.98 Cr | 203.99 Cr | 175.95 Cr | 138.82 Cr |
| Total Assets | 1.17K Cr | 1.82K Cr | 1.80K Cr | 1.82K Cr |
| Total Non Current Assets | 503.98 Cr | 659.55 Cr | 725.46 Cr | 874.27 Cr |
| Other Non Current Assets | 4000.00 | -2000.00 | -1000.00 | -2000.00 |
| Non Current Prepaid Assets | 0.49 Cr | 3.22 Cr | 2.91 Cr | 6.11 Cr |
| Non Current Deferred Taxes Assets | 31.85 Cr | 29.87 Cr | 51.90 Cr | 60.36 Cr |
| Investmentin Financial Assets | 110.54 Cr | 30.34 Cr | 29.06 Cr | 35.53 Cr |
| Held To Maturity Securities | 17.57 Cr | 17.57 Cr | 17.57 Cr | 18.17 Cr |
| Available For Sale Securities | 60.98 Cr | 12.77 Cr | 11.49 Cr | 17.36 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 32.00 Cr | 0.00 | — | — |
| Long Term Equity Investment | 0.00 | — | 0.00 | 0.00 |
| Investment Properties | 2.30 Cr | 2.42 Cr | 2.71 Cr | 14.77 Cr |
| Goodwill And Other Intangible Assets | 0.00 | 0.00 | 1.00 Cr | 9.41 Cr |
| Net PPE | 5.36 Cr | 593.70 Cr | 637.89 Cr | 748.09 Cr |
| Accumulated Depreciation | -2.77 Cr | -745.86 Cr | -691.40 Cr | -563.38 Cr |
| Gross PPE | 8.13 Cr | 1.34K Cr | 1.33K Cr | 1.31K Cr |
| Work In Process | 0.00 | 189.28 Cr | 191.42 Cr | 165.67 Cr |
| Raw Materials | 0.22 Cr | 121.13 Cr | 119.95 Cr | 103.36 Cr |
| Other Receivables | 0.27 Cr | 97.32 Cr | 53.15 Cr | 4.52 Cr |
| Taxes Receivable | 9.10 Cr | 24.99 Cr | 39.24 Cr | 45.85 Cr |
| Accounts Receivable | 169.12 Cr | 505.32 Cr | 454.78 Cr | 432.39 Cr |
| Cash Cash Equivalents And Short Term Investments | 431.93 Cr | 23.15 Cr | 33.37 Cr | 19.90 Cr |
| Cash And Cash Equivalents | 431.93 Cr | 18.20 Cr | 21.48 Cr | 11.60 Cr |
| Cash Equivalents | 395.73 Cr | 10.16 Cr | 10.18 Cr | 10.12 Cr |
| Cash Financial | 36.20 Cr | 8.03 Cr | 11.30 Cr | 1.48 Cr |
| Net Debt | — | 843.34 Cr | 931.00 Cr | 993.24 Cr |
| Other Non Current Liabilities | — | 1000.00 | -1000.00 | 0.17 Cr |
| Current Deferred Taxes Liabilities | — | 12.25 Cr | 5.39 Cr | 0.98 Cr |
| Other Short Term Investments | — | 4.95 Cr | 11.89 Cr | 8.30 Cr |
| Tradeand Other Payables Non Current | — | — | 0.15 Cr | 0.17 Cr |
| Other Intangible Assets | — | — | 1.00 Cr | 9.20 Cr |
| Goodwill | — | — | 0.04 Cr | 0.21 Cr |
| Other Inventories | — | — | -1000.00 | -1000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Ind Swift Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.